Search

Your search keyword '"Sang, Xinting"' showing total 641 results

Search Constraints

Start Over You searched for: Author "Sang, Xinting" Remove constraint Author: "Sang, Xinting"
641 results on '"Sang, Xinting"'

Search Results

10. Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients

15. Immunotherapy prototype Mark 3.0 model in primary liver cancer: adding locoregional stereotactic therapy and prognostic factors classification management

17. Interpretation on the Updated Points of Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

18. Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma

25. Novel Multi-factor Predictive Model for Postoperative Survival in Gallbladder Cancer: A Multi-Center Study

31. Efficacy and safety of subsequent radiotherapy in patients with advanced-stage hepatocellular carcinoma treated with immune checkpoint inhibitors

39. Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery

40. Radiotherapy with Combination Therapy of Immune Checkpoint Inhibitors and Anti-Angiogenic Therapy for Hepatocellular Carcinoma

42. Prediction of Clinical Precision Chemotherapy by Patient‐Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases.

44. Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents

45. Supplementary Figure S1-S3. from Alterations in DNA Damage Repair Genes in Primary Liver Cancer

46. Supplementary Table S1-S4. from Alterations in DNA Damage Repair Genes in Primary Liver Cancer

47. Local-regional therapy combined with toripalimab and lenvatinib in patients with advanced biliary tract cancer

48. Prognostic value of SAT volume and density for predicting the outcome of patients with unresectable HCC treated with lenvatinib plus anti-PD-1 antibodies

Catalog

Books, media, physical & digital resources